Hospital Infection Control Uses EHR to Track C. Difficile
EHR tracks down a source of a common hospital-acquired infection tracing patient movements.
Read More
Once Daily Single-Tablet HIV-1 Therapy Achieves Primary Endpoint
Janssen’s darunavir-based STR, if approved, will be the only complete simplified regimen for HIV-1 in ART-naïve patients.
Many Patients Unaware of Risks of Double Dosing OTC Cold/Flu Medications
It’s imperative healthcare providers strive to have a conversation with patients when prescribing medication.
FDA Approves Once-Weekly Bydureon BCise for Type-2 Diabetes
The new once-weekly injectable device provides HbA1c reduction with added weight loss.
Pivotal Phase 3 Trial in Psoriasis Vulgaris Treatment
The development of MC2-01 Cream is designed to focus on the acute and long-term needs of patients.
Where to Target HIV Prevention and Care to Reach MSM
HIV infection is hyperendemic among MSM throughout many areas of the US, specifically in the South.
FDA Rejects Xyosted for Hypogonadism
FDA sends response letter for deficiencies found in Antares Pharma’s QuickShot Testosterone auto injector.
New Therapy Could Mark "Functional Cure" for HIV
HIV virus stayed dormant for more than 2 weeks after Tat inhibitor dCA ‘blocked-and-locked’ HIV-infected cells.
One Change To Drastically Improve Hypertension Diagnosis
Measurements of SBP at 3 or 5 minutes tend to over-predict the proportion of hypertensive subjects.
Lyle Petersen, MD, MPH: What Do We Now Know About Zika Virus?
New findings show that some babies appear to be normal at birth but have developmental problems later on.
HPV Prevalence Decreases Suggesting Herd Immunity Benefits
From 2009–2014, vaccine-type HPV among unvaccinated 18–26 year olds decreased 50%.
Secondary Prophylaxis Did Not Significantly Reduce CDI Rates
While vancomycin SP reduced the recurrent rate 7.5%, compared to metronidazole, it was not statistically significance.
DR/ER-MPH Demonstrates Positive Phase 3 ADHD Results
Evening-dosed psychostimulant is the first long-acting MPH single-dose formulation to show improvements in at-home early morning functional impairment.
FDA Accepts sNDA Filing for Pneumonia Drug
If approved, healthcare providers will have much needed treatment for management of HABP/VABP infections.
Physician Roll Call: Hottest Topic in Infectious Disease
What infectious disease topics should you know about? Find out what these ID doctors have to say.
FDA Approves Stelara for Plaque Psoriasis
Findings show Janssen's drug led to significant skin clearance results at week 12.
Steve Pergam, MD, MPH, FIDSA: Legionella Infections in Immunocompromised Patients
Infections in immunocompromised patients continue to rise because of more enhanced diagnostics and increased cultures.
Whole-Body Hyperthermia Can Improve MDD Outcomes
WBH holds promise as a safe, rapid-acting, antidepressant modality with a prolonged therapeutic benefit.
Baloxavir Marboxil Demonstrates Positive Phase 3 Influenza Results
The CAPSTONE-1 trial demonstrated a new antiviral aimed to reduce flu symptoms with possible NDA submission.
Louise Ivers, MD, MPH, DTMH: Advancements Toward Global Cholera Management
The UN and WHO aim to reduce the burden of cholera globally by 90% reduction in deaths by 2030.
Kirsten Lyke, MD: Progress Toward Malaria Vaccine
Since 2000 there's been a 30% overall reduction in malaria, however, a vaccine is needed as another tool.
Tenapanor Supplants Support for 2018 NDA Submission
The well tolerated potential IBS-C drug reduced abdominal pain by at least 30%.
Ebola Vaccines Provide Year-Long Immune Response
The clinical trial yielded valuable information essential for the continued development of the 2 Ebola vaccine candidates.
Shibani Mukerji, MD, PhD: What We Know About How HIV Affects Neurocognition
Catch up on what you missed in how HIV affects the brain.
Daniel Lucey, MD: Why There's a Yellow Fever Vaccine Shortage
Learn more about the decrease in yellow fever vaccine production that will last until mid-2018.
James McKinnell, MD: Outcomes of Delafloxacin Treatment for Skin Structure Infections
Why is delafloxacin unique compared to other fluoroquinolones? Find out more.
Peggy Honein, PhD, MPH: Zika Infection in Pregnancy
What expecting mothers with Zika virus should know.
Rochelle Walensky, MD, MPH: HIV Costs, Present and Future
Rochelle Walensky, MD, MPH, Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, discusses the current and future state of costs for HIV medications.
Rochelle Walensky, MD, MPH: The Future for HIV Drug Prices
Rochelle Walensky, MD, MPH, Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, discusses the future for HIV drug prices.
Brianna Norton, DO: Hepatitis C Treatment
Brianna Norton, DO, MPH, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, talks about challenges of Hepatitis C treatment.